Dupilumab added to standard therapies significantly reduced the use of maintenance oral corticosteroids (OCS) by 70% on average. Source: BioSpace

Shares of Voyager have fallen more than 12 percent in premarket trading after Sanofi Genzyme walked away from its $845M gene therapy treatment for Parkinson’s disease. Source: BioSpace

Based on feedback from the FDA, Stemline remains on track to begin submission of its BLA in the 4Q17-1Q18 timeframe. Source: BioSpace

The two companies will jointly develop Imeglimin for the treatment of type 2 diabetes in Japan. Source: BioSpace

Late on Friday, Merck announced that it had pulled its application for Keytruda in combination with pemetrexed and carboplatin as a first-line treatment for metastatic nonsquamous NSCLC from the EMA.…

Kymera Therapeutics launched with a $30M Series A financing which was lead by Atlas Venture. Source: BioSpace

As part of consolidation program, Shire is looking to sell a manufacturing facility in Milford, MA that it gained through its 2015 acquisition of Baxalta. Source: BioSpace

Want to work for a company having a growth spurt? Source: BioSpace

Insys continues to receive an optics beating in the wake of the charges against company founder John Kapoor and multiple executives surrounding illegal sales practices of its cancer pain drug.…

Amazon, as most everyone knows, has its fingers in a lot of pies. Source: BioSpace